SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-034310
Filing Date
2019-06-06
Accepted
2019-06-06 16:32:23
Documents
9
Period of Report
2019-06-03
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-11153_18k.htm 8-K 36804
2 EX-3.1 a19-11153_1ex3d1.htm EX-3.1 19548
3 EX-4.1 a19-11153_1ex4d1.htm EX-4.1 6121
4 EX-99.1 a19-11153_1ex99d1.htm EX-99.1 10818
5 EX-99.2 a19-11153_1ex99d2.htm EX-99.2 12797
6 GRAPHIC g111531kg03i001.gif GRAPHIC 81917
7 GRAPHIC g111531mmi001.jpg GRAPHIC 2834
8 GRAPHIC g111531kei001.gif GRAPHIC 8007
9 GRAPHIC g111531kg01i001.gif GRAPHIC 250964
  Complete submission text file 0001104659-19-034310.txt   561232
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 19882954
SIC: 2834 Pharmaceutical Preparations